Literature DB >> 2387774

Quinaldopeptin, a novel antibiotic of the quinomycin family.

S Toda1, K Sugawara, Y Nishiyama, M Ohbayashi, N Ohkusa, H Yamamoto, M Konishi, T Oki.   

Abstract

Quinaldopeptin, a new type of quinomycin antibiotic, was isolated from the culture of Streptoverticillium album strain Q132-6. The antibiotic exhibited strong in vitro antimicrobial and cytotoxic activity and significantly prolonged the survival time of mice inoculated with a murine tumor. Quinaldopeptin is a symmetric cyclic peptide linked only by peptide bonds and differs from known antibiotics of the quinomycin family by the lack of ester linkage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387774     DOI: 10.7164/antibiotics.43.796

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

1.  Actinoquinolines A and B, anti-inflammatory quinoline alkaloids from a marine-derived Streptomyces sp., strain CNP975.

Authors:  Hossam M Hassan; Chollaratt Boonlarppradab; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2016-05-25       Impact factor: 2.649

Review 2.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

3.  New 3-Hydroxyquinaldic Acid Derivatives from Cultures of the Marine Derived Actinomycete Streptomyces cyaneofuscatus M-157.

Authors:  Francisco Javier Ortiz-López; Elsa Alcalde; Aida Sarmiento-Vizcaíno; Caridad Díaz; Bastien Cautain; Luis A García; Gloria Blanco; Fernando Reyes
Journal:  Mar Drugs       Date:  2018-10-08       Impact factor: 5.118

4.  Stereoselective Allylic Alkylations of Amino Ketones and Their Application in the Synthesis of Highly Functionalized Piperidines.

Authors:  Cynthia Prudel; Kai Huwig; Uli Kazmaier
Journal:  Chemistry       Date:  2020-02-21       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.